A case of fatal interstitial lung disease after first cycle CHOP with etoposide combination therapy in malignant lymphoma patient
분야
의약학 > 내과학
저자
( Hyung Chul Park ) , ( Jae Sook Ahn ) , ( Deok Hwan Yang ) , ( Sung Hoon Jung ) , ( Soo Young Bae ) , ( Huong Thi Thanh Tran ) , ( Mi Young Kim ) , ( Yeo Kyeoung Kim ) , ( Hyeoung Joon Kim ) , ( Je Jung Lee )
발행기관
대한내과학회
간행물정보
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 267(총1페이지)
파일형식
42846684.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Despite the difference in frequency, over at least 40 chemotherapic agents used currently are known as having pulmonary toxicity. Among these, cyclophosphamide and etoposide are relatively common agents being toxic to the lung. Granulocyte colony-stimulating factor or granulocyte macrophage colony stimulating factor related lung injury has been also reported during the treatment of cytotoxic chemotherapy-induced neutropenia. But, most reported cases were developed drug induced interstitial lung disease after several cycles of chemotherapy. Here in, we report a patient with Non-Hodgkin``s lymphoma in whom fatal interstitial lung disease were developed after first cycle cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP) with etoposide combination therapy and G-CSF administration during recovery. A 69-year-old man was admitted to our hospital with multiple palpable mass in the both neck and groin and he had been diagnosed as peripheral T-cell lymphoma, nos with stage IV so, first cycle of CHOP with etoposide (CHOP-E) combination chemotherapy was performed. Over 8 days after chemotherapy, neutropenia has been developed and G-CSF (5ug/kg/day, IV) was administered during 7 days. After 30 days of 1st cycles combination chemotherapy, he was hospitalized for 2nd CHOP-E chemotherapy and he complained of exertional dyspnea without any infectious symptom. The chest CT showed that diffuse ground glass opacities with reticulation in peripheral area were newly developed in both lungs. He was diagnosed as drug induced interstitial pneumonitis and prednisone 125 mg/day was administered immediately. However the patient showed irreversible clinical course, he was died of respiratory failure after 38 days from the diagnosis of interstitial pneumonitis.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.